BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 27625633)

  • 1. Alterations of Phosphodiesterases in Adrenocortical Tumors.
    Hannah-Shmouni F; Faucz FR; Stratakis CA
    Front Endocrinol (Lausanne); 2016; 7():111. PubMed ID: 27625633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How does cAMP/protein kinase A signaling lead to tumors in the adrenal cortex and other tissues?
    Almeida MQ; Stratakis CA
    Mol Cell Endocrinol; 2011 Apr; 336(1-2):162-8. PubMed ID: 21111774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular Genetic and Genomic Alterations in Cushing's Syndrome and Primary Aldosteronism.
    Kamilaris CDC; Stratakis CA; Hannah-Shmouni F
    Front Endocrinol (Lausanne); 2021; 12():632543. PubMed ID: 33776926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphodiesterase 11A expression in the adrenal cortex, primary pigmented nodular adrenocortical disease, and other corticotropin-independent lesions.
    Boikos SA; Horvath A; Heyerdahl S; Stein E; Robinson-White A; Bossis I; Bertherat J; Carney JA; Stratakis CA
    Horm Metab Res; 2008 May; 40(5):347-53. PubMed ID: 18491255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A cAMP-specific phosphodiesterase (PDE8B) that is mutated in adrenal hyperplasia is expressed widely in human and mouse tissues: a novel PDE8B isoform in human adrenal cortex.
    Horvath A; Giatzakis C; Tsang K; Greene E; Osorio P; Boikos S; Libè R; Patronas Y; Robinson-White A; Remmers E; Bertherat J; Nesterova M; Stratakis CA
    Eur J Hum Genet; 2008 Oct; 16(10):1245-53. PubMed ID: 18431404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphodiesterase 11A (PDE11A) and genetic predisposition to adrenocortical tumors.
    Libé R; Fratticci A; Coste J; Tissier F; Horvath A; Ragazzon B; Rene-Corail F; Groussin L; Bertagna X; Raffin-Sanson ML; Stratakis CA; Bertherat J
    Clin Cancer Res; 2008 Jun; 14(12):4016-24. PubMed ID: 18559625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adrenocortical tumorigenesis: Lessons from genetics.
    Kamilaris CDC; Hannah-Shmouni F; Stratakis CA
    Best Pract Res Clin Endocrinol Metab; 2020 May; 34(3):101428. PubMed ID: 32507359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adrenal hyperplasia and adenomas are associated with inhibition of phosphodiesterase 11A in carriers of PDE11A sequence variants that are frequent in the population.
    Horvath A; Giatzakis C; Robinson-White A; Boikos S; Levine E; Griffin K; Stein E; Kamvissi V; Soni P; Bossis I; de Herder W; Carney JA; Bertherat J; Gregersen PK; Remmers EF; Stratakis CA
    Cancer Res; 2006 Dec; 66(24):11571-5. PubMed ID: 17178847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Germline Variants in Phosphodiesterase Genes and Genetic Predisposition to Pediatric Adrenocortical Tumors.
    Pinto EM; Faucz FR; Paza LZ; Wu G; Fernandes ES; Bertherat J; Stratakis CA; Lalli E; Ribeiro RC; Rodriguez-Galindo C; Figueiredo BC; Zambetti GP
    Cancers (Basel); 2020 Feb; 12(2):. PubMed ID: 32098292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphodiesterase 11A (PDE11A) gene defects in patients with acth-independent macronodular adrenal hyperplasia (AIMAH): functional variants may contribute to genetic susceptibility of bilateral adrenal tumors.
    Vezzosi D; Libé R; Baudry C; Rizk-Rabin M; Horvath A; Levy I; René-Corail F; Ragazzon B; Stratakis CA; Vandecasteele G; Bertherat J
    J Clin Endocrinol Metab; 2012 Nov; 97(11):E2063-9. PubMed ID: 22996146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormalities of cAMP signaling are present in adrenocortical lesions associated with ACTH-independent Cushing syndrome despite the absence of mutations in known genes.
    Bimpaki EI; Nesterova M; Stratakis CA
    Eur J Endocrinol; 2009 Jul; 161(1):153-61. PubMed ID: 19429701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A genome-wide scan identifies mutations in the gene encoding phosphodiesterase 11A4 (PDE11A) in individuals with adrenocortical hyperplasia.
    Horvath A; Boikos S; Giatzakis C; Robinson-White A; Groussin L; Griffin KJ; Stein E; Levine E; Delimpasi G; Hsiao HP; Keil M; Heyerdahl S; Matyakhina L; Libè R; Fratticci A; Kirschner LS; Cramer K; Gaillard RC; Bertagna X; Carney JA; Bertherat J; Bossis I; Stratakis CA
    Nat Genet; 2006 Jul; 38(7):794-800. PubMed ID: 16767104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Update of Genetic and Molecular Causes of Adrenocortical Hyperplasias Causing Cushing Syndrome.
    Berthon A; Bertherat J
    Horm Metab Res; 2020 Aug; 52(8):598-606. PubMed ID: 32097969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phosphodiesterase 11 (Pde11a) knockout mouse expressed functional but reduced Pde11a: Phenotype and impact on adrenocortical function.
    Levy I; Szarek E; Maria AG; Starrost M; De La Luz Sierra M; Faucz FR; Stratakis CA
    Mol Cell Endocrinol; 2021 Jan; 520():111071. PubMed ID: 33127481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unraveling the molecular basis of micronodular adrenal hyperplasia.
    Horvath A; Stratakis CA
    Curr Opin Endocrinol Diabetes Obes; 2008 Jun; 15(3):227-33. PubMed ID: 18438169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Many Faces of Primary Aldosteronism and Cushing Syndrome: A Reflection of Adrenocortical Tumor Heterogeneity.
    Mete O; Duan K
    Front Med (Lausanne); 2018; 5():54. PubMed ID: 29594118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A genetic and molecular update on adrenocortical causes of Cushing syndrome.
    Lodish M; Stratakis CA
    Nat Rev Endocrinol; 2016 May; 12(5):255-62. PubMed ID: 26965378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New genes and/or molecular pathways associated with adrenal hyperplasias and related adrenocortical tumors.
    Stratakis CA
    Mol Cell Endocrinol; 2009 Mar; 300(1-2):152-7. PubMed ID: 19063937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclic AMP and c-KIT signaling in familial testicular germ cell tumor predisposition.
    Azevedo MF; Horvath A; Bornstein ER; Almeida MQ; Xekouki P; Faucz FR; Gourgari E; Nadella K; Remmers EF; Quezado M; de Alexandre RB; Kratz CP; Nesterova M; Greene MH; Stratakis CA
    J Clin Endocrinol Metab; 2013 Aug; 98(8):E1393-400. PubMed ID: 23771924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional characteristics and research trends of PDE11A in human diseases (Review).
    Kong G; Lee H; Vo TT; Juang U; Kwon SH; Park J; Park J; Kim SH
    Mol Med Rep; 2022 Oct; 26(4):. PubMed ID: 35929507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.